Instrument Inactif

Communiqués US Rare Earth Minerals Inc Other OTC

Actions

US9034101082

Recherche biotechnologique et médicale

Cours en clôture Other OTC Autres places de cotation
- ^USD	-

15/05	Bioxytran, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI
15/04	Bioxytran, Inc. publie ses résultats pour l'exercice clos le 31 décembre 2025	CI

Communiqués

29/05	Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25	AQ
20/03	BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT	AQ
04/03	Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M	AQ
23/02	Bioxytran Initiates Research Collaboration with University of Georgia to Evaluate Drug Candidate's Ability to Block H5N1 Bird Flu Virus	AQ
17/02	Bioxytran, Inc. Announces Commercial Distribution Agreement with Khoury Medical LTD for A-SUQAR Dietary Supplement	AQ
11/02	Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran	AQ
02/02	Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics	AQ
29/01	Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline	AQ
13/11	Bioxytran Announces Initiation of Coverage of its Stock by Independent Research	AQ
29/10/25	Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug	AQ
15/08/25	Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation	AQ
07/08/25	Bioxytran’s Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment	AQ
18/06/25	Bioxytran Secures a Source of GMP Quality Camel Hemoglobin	AQ
03/06/25	Bioxytran’s Groundbreaking Stroke & Alzheimer’s Tech Gains Validation That Measures Oxygenation Uptake During Strokes	AQ
21/05/25	Bioxytran’s Antiviral Breakthrough Featured in University of Georgia’s $100M HPAI Poultry Innovation Grand Challenge Submission	AQ
12/05/25	Bioxytran Completes Dose Optimization of Antiviral, ProLectin-M	AQ
11/04/25	Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements	AQ
19/03/25	Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens	AQ
12/03/25	Bioxytran Develops a Groundbreaking Treatment to Combat Bird Flu in Egg Laying Chickens Potentially Saving Billions	AQ
22/01/25	Bioxytran Secures $1.6 million SPA to Extinguish Note & Fund Clinical Development	AQ
10/01/25	Bioxytran’s Cancer Preprint Reveals Potential to Enhance Most Immunotherapy Drugs	AQ
07/01/25	Bioxytran Announces Government Interest After Initial BARDA Techwatch Light Meeting	AQ
18/07/24	Bioxytran Launches Joint Venture with the Heme Foundation for Development of Universal Oxygen Carrier	AQ
17/07/24	Bioxytran : Launches Joint Venture with the Heme Foundation for Development of a Universal Oxygen Carrier Form 8 K	PU
27/06/24	Bioxytran’s Advisor Releases Book on Hyperbaric Oxygenation Related to Stroke & Alzheimer’s Patients	AQ